title: The authors reply.
authors.forename: Alberto
authors.initials: A
authors.lastname: Lazaro
authors.forename: Blanca
authors.initials: B
authors.lastname: Humanes
authors.forename: Juan C
authors.initials: JC
authors.lastname: Jado
authors.forename: Alberto
authors.initials: A
authors.lastname: Tejedor
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents; D017209:Apoptosis / Q000187:drug effects*; D015377:Cilastatin / Q000494:pharmacology*; D002945:Cisplatin; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000517:prevention & control*; D008297:Male; D011480:Protease Inhibitors / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D011480:Protease Inhibitors; D015377:Cilastatin; D002945:Cisplatin